Brevan Howard Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Brevan Howard Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$619K	Buy	41,021 +2,685	+7%	+$46.9K	﹤0.01%	1337
2026 Q1	$735K	Buy	38,336 +4,245	+12%	+$92.2K	0.01%	1078
2025 Q4	$749K	Sell	34,091 -92,797	-73%	-$1.67M	0.01%	901
2025 Q3	$1.54M	Buy	126,888 +32,154	+34%	+$435K	0.01%	688
2025 Q2	$1.77M	Buy	94,734 +83,955	+779%	+$1.66M	0.01%	795
2025 Q1	$207K	Sell	10,779 -42,062	-80%	-$1.23M	﹤0.01%	973
2024 Q4	$1.9M	Buy	52,841 +30,909	+141%	+$1.05M	0.01%	294
2024 Q3	$930K	Buy	+21,932	New	+$930K	0.01%	477
2024 Q2	–	Sell	-12,087	Closed	-$428K	–	1399
2024 Q1	$428K	Buy	+12,087	New	+$324K	﹤0.01%	508

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Brevan Howard Capital Management's TNDM Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Tandem Diabetes Care (TNDM) stake by 7% in Q2 2026, buying an estimated $46.9K and bringing the position to 41,021 shares worth $619K. The position accounts for ﹤0.01% of the portfolio, ranked #1337.

Brevan Howard Capital Management first reported a position in TNDM in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.9M in Q4 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

Brevan Howard Capital Management held 41,021 shares of Tandem Diabetes Care worth $619K as of Q2 2026.
Brevan Howard Capital Management bought 2,685 Tandem Diabetes Care shares in Q2 2026, an estimated $46.9K.
Tandem Diabetes Care made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1337 holding.
Brevan Howard Capital Management first reported a position in Tandem Diabetes Care in Q1 2024 and has held it in 9 quarters since.
Brevan Howard Capital Management's Tandem Diabetes Care position peaked at $1.9M in Q4 2024.
274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.